First in Human Study to Assess the Safety, Tolerability and Pharmacokinetics of EDI048 in Healthy Volunteers
NCT05275855
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
110
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Volunteers
Interventions
DRUG:
EDI048
OTHER:
Placebo
Sponsor
Novartis Pharmaceuticals